Stemina Biomarker Discovery: devTOX DiscoveryTM and devTOX quickPredictTM [SOT 2013]
Stemina’s CEO, Beth Donley, presented Stemina’s new in vitro assay for prediction of developmental toxicity: devTOX quickPredict.
View the presentation slides.
504 S. Rosa Rd. Suite 150
Madison, WI 53719
Stemina’s neurological disorders business unit has developed a tool to aid in the earlier diagnosis of autism spectrum disorder.